Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Valera Pharmaceuticals Inc (VLRX) since 2006 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Valera Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 1305409.
Total stock buying since 2006: $246,530.
Total stock sales since 2006: $209,251.
Total stock option exercises since 2006: $375,624.
▪ Recent SEC 13D filings for all companies
▪ Funds & ETFs holding VLRX
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2007 | 0 | $0 | 25,208 | $209,251 | 125,208 | $375,624 |
| 2006 | 28,000 | $246,530 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2007-04 | 0 | $0 | 0 | $0 | 100,000 | $300,000 |
| 2007-02 | 0 | $0 | 25,208 | $209,251 | 25,208 | $75,624 |
| 2006-05 | 16,000 | $138,530 | 0 | $0 | 0 | $0 |
| 2006-02 | 12,000 | $108,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2007-04-02 | Tierney David S (President and CEO) | Option Ex | 100,000 | 3.00 | 300,000 |
| 2007-02-26 | Huckel Hubert E Md (Director) | Sale | 25,208 | 8.30 | 209,251 |
| 2007-02-26 | Huckel Hubert E Md (Director) | Option Ex | 25,208 | 3.00 | 75,624 |
| 2006-05-25 | Silverman Howard (Director) | Buy | 5,000 | 7.90 | 39,500 |
| 2006-05-25 | Tierney David S (President and CEO) | Buy | 1,000 | 7.73 | 7,730 |
| 2006-05-04 | Silverman Howard (Director) | Buy | 10,000 | 9.13 | 91,300 |
| 2006-02-02 | Drechsler Andrew T (Chief Financial Officer) | Buy | 1,600 | 9.00 | 14,400 |
| 2006-02-02 | Perron Pete (VP, Sales) | Buy | 500 | 9.00 | 4,500 |
| 2006-02-02 | Kuzma Petr F (VP, Research and Dev) | Buy | 1,100 | 9.00 | 9,900 |
| 2006-02-02 | Tierney David S (President and CEO) | Buy | 5,500 | 9.00 | 49,500 |
| 2006-02-02 | Huckel Hubert E Md (Director) | Buy | 3,300 | 9.00 | 29,700 |
Insider trading activities including stock purchases, stock sales, and option exercises of VLRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Valera Pharmaceuticals Inc (symbol VLRX, CIK number 1305409) see the Securities and Exchange Commission (SEC) website.